---
title: "Ekso Bionics 定價 580 萬美元的私募配售"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/273243676.md"
description: "Ekso Bionics (EKSO) 於 2026 年 1 月 20 日宣佈進行 580 萬美元的私募，涉及 5,852 股 B 系列優先股和最多 360,000 股普通股的認股權證。每股優先股的價值為 1,000 美元，並且可以隨時轉換為普通股"
datetime: "2026-01-21T14:16:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273243676.md)
  - [en](https://longbridge.com/en/news/273243676.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273243676.md)
---

# Ekso Bionics 定價 580 萬美元的私募配售

Ekso Bionics (EKSO) on Wednesday said it entered into securities purchase agreements on Jan. 20, 2026, with institutional and accredited investors for a private placement of 5,852 shares of Series B preferred stock and warrants to buy up to 0.36M common shares. Each preferred share has a stated value of $1,000 and may be converted at any time into ...

### 相關股票

- [XBI.US](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [XHE.US](https://longbridge.com/zh-HK/quote/XHE.US.md)
- [IBB.US](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [FBT.US](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [EKSO.US](https://longbridge.com/zh-HK/quote/EKSO.US.md)
- [LABD.US](https://longbridge.com/zh-HK/quote/LABD.US.md)
- [PBE.US](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/zh-HK/quote/BIB.US.md)
- [SBIO.US](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [IHI.US](https://longbridge.com/zh-HK/quote/IHI.US.md)
- [CHRN.US](https://longbridge.com/zh-HK/quote/CHRN.US.md)

## 相關資訊與研究

- [朗齊生醫 LXP108 一期臨牀試驗安全性表現穩健 開發進程持續向前](https://longbridge.com/zh-HK/news/285172960.md)
- [鉅亨速報 - Factset 最新調查：Cytokinetics IncCYTK-US 的目標價調升至 98 元，幅度約 3.16%](https://longbridge.com/zh-HK/news/285260197.md)
- [鉅亨速報 - Factset 最新調查：Krystal Biotech Inc(KRYS-US) EPS 預估上修至 7.99 元，預估目標價為 311.00 元](https://longbridge.com/zh-HK/news/285129897.md)
- [鉅亨速報 - Factset 最新調查：Kymera Therapeutics Inc(KYMR-US) EPS 預估下修至-3.46 元，預估目標價為 119.00 元](https://longbridge.com/zh-HK/news/285070732.md)
- [台股創新高！信邦台光電營收飆升，AI 需求驅動醫療技術合作蓄勢待發](https://longbridge.com/zh-HK/news/285170388.md)